SCODiA Report by MLBI Lab

Single-Cell Landscape of the Colon Cancer Microenvironment: Cellular Dynamics, Genomic Instability, and Immune Dysregulation

This report delineates the single-cell landscape of human colon tissue, comparing normal and tumor conditions. Key findings reveal that tumor-origin Intestinal Epithelial cells exhibit hallmarks of malignancy, including aneuploidy and significant upregulation of cell cycle and oncogenic pathways. The tumor microenvironment is profoundly reshaped, characterized by an influx of pro-tumorigenic fibroblasts and a complex immune infiltrate marked by expanded immunosuppressive T cell subsets (Tregs, Th17, Th22) and M2-like macrophages. Altered cell-cell interactions, including immune checkpoints and adhesion molecules, further contribute to immune evasion and tumor progression.

Contents

  1. Dataset overview
  2. UMAP Visualization of Cell Populations by Condition, Sample, Cell Type, and Ploidy Status
  3. Marker Gene Expression and Cell Type Annotation Validation on UMAP
  4. Celltype_subset Marker Expression Dot Plot Analysis
  5. Analysis of Copy Number Variations in Intestinal Epithelial and Unassigned Cells
  6. CNV-Based UMAP Embedding and Cell Annotation Analysis in Colon Tissue
  7. Colon Tissue Minor Cell Type Population Analysis
  8. T Cell Subset Population Analysis in Colon Normal vs. Tumor Conditions
  9. Macrophage Subset Population Analysis in Colon Normal vs. Tumor Tissues
  10. T Cell Subset Population Shifts in Colon Cancer
  11. Differential Macrophage Subset Proportions in Colon Tumor Microenvironment
  12. Ploidy Analysis of Tumor-Origin and Unassigned Cells in Normal and Tumor Colon Samples
  13. Normal Colon Cell-Cell Interaction Patterns Focused on Epithelial and T Cells
  14. Tumor 미세환경 내 Cell-Cell 상호작용 분석: 주요 Ligand-Receptor 쌍 및 생물학적 함의
  15. Cell-Cell Interaction Analysis of Immune Checkpoint and Cell Cycle Related Genes in Colon Tissue
  16. Condition-Specific Cell-Cell Interaction Patterns in Colon Tissue
  17. Intestinal Epithelial Cell Condition-Specific Surfaceome Markers
  18. Cell-Type Specific Surfaceome Markers for Macrophage Subtypes in Human Colon
  19. Fibroblast Condition-Specific Surfaceome Markers in Colon Tissue
  20. Condition-Specific Surfaceome Markers in CD4+ T cells
  21. Intestinal Epithelial Cell Cycle Deregulation in Colon Tumorigenesis
  22. Intestinal Epithelial Cell Gene Ontology (GSA) Analysis: Ploidy and Tumor-Associated Pathway Shifts
  23. Major Cell Type GSEA for Colon Tissue: Insights into Tumor Microenvironment Pathways
  24. Discussion
  25. Query List

0. Dataset overview

Dataset Summary

Precomputed Results

Available Cell Types for Specific Analyses

1. UMAP Visualization of Cell Populations by Condition, Sample, Cell Type, and Ploidy Status

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents UMAP (Uniform Manifold Approximation and Projection) plots, which are commonly used for dimensionality reduction and visualization of single-cell RNA-seq data. These plots project high-dimensional gene expression data into a 2D space, allowing for the visual inspection of cellular heterogeneity and relationships. The UMAPs are colored by various metadata features: condition, sample, celltype_major, celltype_minor, ploidy_dec, and celltype_subset. This comprehensive visualization helps in understanding the overall structure of the dataset, assessing the quality of cell type annotations, evaluating potential batch effects, and identifying disease-specific or cell-specific patterns.

Visual Summary

Condition

The UMAP colored by condition shows a clear separation, with a large, dense cluster prominently occupied by 'tumor' cells (dark blue) and other regions predominantly by 'normal' cells (maroon). However, there is also significant mixing of 'normal' and 'tumor' cells in several areas, indicating shared cell types or similar cellular states across both conditions, or immune/stromal infiltration into the tumor microenvironment.

Sample

The sample UMAP displays a remarkable intermixing of cells from various samples across the major clusters. This suggests that the data integration process was successful in minimizing strong sample-specific batch effects, allowing for robust comparisons across samples. While some small peripheral clusters might show slight enrichment for certain samples, the overall embedding structure is not dominated by individual sample identities.

Cell Type (Major, Minor, Subset)

The UMAPs colored by celltype_major, celltype_minor, and celltype_subset consistently demonstrate well-defined and distinct clusters for the annotated cell types at all hierarchical levels.

Ploidy Dec

The ploidy_dec UMAP reveals a striking pattern: 'Aneuploid' cells (maroon) are highly concentrated in a specific region of the UMAP space, largely overlapping with the main Intestinal Epithelial cell cluster. In contrast, 'Diploid' cells (yellow) are widely distributed across the entire UMAP, encompassing most other cell types and regions. Very few 'Unclear' cells (dark blue) are observed.

Biological Interpretation

The comprehensive UMAP analysis provides several key biological insights into the colon tissue dataset:

  1. Distinct Cellular Landscapes in Normal vs. Tumor Conditions: The condition UMAP highlights that while there are shared cellular components between normal and tumor colon tissue, there are also significant shifts in cell populations or states specific to the tumor microenvironment. The large 'tumor'-enriched cluster suggests the presence of tumor-specific malignant cells and/or immune/stromal cells that are heavily reprogrammed in the tumor context.
  2. Robust Cell Type Annotation: The excellent separation of major, minor, and subset cell types into distinct clusters confirms the high quality of the cell type annotations. This provides a strong foundation for downstream differential gene expression, pathway analysis, and cell-cell interaction studies, ensuring that comparisons are made between genuinely distinct cell populations. The identification of various immune, stromal, and epithelial cell subsets aligns with the known cellular complexity of the colon and its tumor microenvironment.
  3. Identification of Malignant Cells by Ploidy: The most impactful finding from these UMAPs is the strong co-localization of 'Aneuploid' cells with the Intestinal Epithelial cell cluster, especially within the 'tumor' condition. Given that "Intestinal Epithelial cell" is designated as the "Tumor origin celltype" and aneuploidy is a hallmark of cancer, this observation provides strong evidence for the successful identification and clustering of the malignant epithelial cells [1]. These aneuploid epithelial cells likely represent the cancerous cell population in the colon tumor samples, distinguishing them from normal epithelial cells or other stromal and immune cells, which are predominantly diploid. This distinction is critical for studying tumor-intrinsic biology and identifying potential therapeutic targets within the malignant cells.

Annotation Notes

The consistency and distinctness of cell type clusters across major, minor, and subset levels suggest a robust annotation pipeline. The successful integration of samples, as evidenced by the intermixing in the sample UMAP, indicates that biological variations rather than technical artifacts drive the observed cell clustering. The clear pattern of aneuploidy supporting the identification of tumor epithelial cells further validates the biological relevance of the annotations.

---

References:

[1] Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. *Cell*, 144(5), 646–674. PubMed Search: "Hallmarks of Cancer"

2. Marker Gene Expression and Cell Type Annotation Validation on UMAP

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis visualizes the expression of a panel of known marker genes on a UMAP projection, alongside the celltype_minor annotation. The primary goal is to validate the consistency and specificity of the minor cell type annotations within the single-cell RNA-seq dataset by examining the spatial distribution of these key gene expressions. This helps confirm the identity of distinct cell populations.

Visual Summary

The UMAP plots clearly display cell clusters based on their transcriptional profiles. The celltype_minor plot serves as a reference, showing discrete clusters corresponding to annotated cell types such as T cell CD4+, T cell CD8+, B cell, Plasma cell, Intestinal Epithelial cell, Macrophage, Dendritic cell, Fibroblast, and Endothelial cell.

Individual gene expression plots reveal distinct patterns:

Biological Interpretation

The observed gene expression patterns on the UMAP are highly consistent with the established roles of these genes as markers for specific cell types. This provides strong validation for the celltype_minor annotations generated from the single-cell RNA-seq data.

Annotation Notes

The strong agreement between the canonical marker gene expression and the celltype_minor assignments confirms that the clustering and annotation processes have successfully captured biologically distinct cell populations present in the colon tissue. This robust cell type identification forms a reliable basis for further in-depth biological investigations related to conditions (normal vs. tumor) and other metadata features within the dataset.

3. Celltype_subset Marker Expression Dot Plot Analysis

Report figure

[Analysis Visualization Results]...

Analysis Overview

This dot plot visualizes the expression of marker genes across various celltype_subset populations identified in the single-cell RNA-seq data from human colon tissue. Each row represents a celltype_subset, and each column represents a marker gene. The size of the dot indicates the fraction of cells within that cell type expressing the gene, while the color intensity (from light red to dark red) represents the mean expression level of the gene within that cell type. This analysis serves as a crucial step for validating the quality and specificity of the celltype_subset annotations based on known biological markers.

Visual Summary

The dot plot displays a clear diagonal pattern, indicating that distinct sets of genes are preferentially expressed in specific celltype_subset groups. This "block-like" structure on the diagonal is a strong visual indicator of well-defined cell populations with unique transcriptional signatures.

Biological Interpretation

The marker expression patterns largely support the assigned celltype_subset annotations within the human colon scRNA-seq dataset.

Immune Cell Subsets

B cell subsets:

T cell subsets:

Myeloid cells:

Epithelial and Stromal Cells

Intestinal Epithelial cell subsets:

Stromal cell subsets:

Endothelial cell subsets

Annotation Notes

The dot plot strongly validates the celltype_subset annotations for most populations in this colon single-cell RNA-seq dataset.

4. Analysis of Copy Number Variations in Intestinal Epithelial and Unassigned Cells

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis visualizes estimated copy number variations (CNVs) in Intestinal Epithelial cells (identified as the tumor-origin cell type) and 'unassigned' cells, grouped by sample. The primary goal is to identify recurrent genomic amplifications or deletions across different samples, even within cell populations inferred to be largely diploid. The provided heatmap displays log2(Copy Number Ratio) values across genomic regions, and a summary highlights significantly amplified cytogenetic bands and their frequencies.

Visual Summary

The main visualization is a CNV heatmap showing log2(CNR) values across chromosomes (x-axis, ordered from 1 to 22) for various cell groups (y-axis). Each row represents a sample group, specifically focusing on "Intestinal Epithelial cell" and "unassigned" cell types, with a prefix indicating their inferred ploidy status (e.g., "Diploid T_cacX" or "Diploid B_cacX"). Red and yellow hues indicate copy number amplifications (log2(CNR) > 0), while blue hues indicate deletions (log2(CNR) < 0).

Key observations from the heatmap:

The accompanying summary plot (right panel) provides a detailed view of significantly amplified regions:

Biological Interpretation

The analysis specifically focuses on Intestinal Epithelial cells (the tumor-origin cell type in this dataset) and 'unassigned' cells. The observation of focal CNVs within these groups, even when largely inferred as "Diploid", is highly relevant to cancer biology. Many early-stage or less aggressive tumors can maintain an overall diploid karyotype while acquiring specific oncogenic CNVs.

Clinical or Translational Implications

The identification of recurrent genomic amplifications, especially those involving known oncogenes like *MYC* on chromosome 8, offers valuable insights into the genetic landscape of colorectal cancer. These findings could potentially inform:

Annotation Notes

The use of ploidy_dec to label cell groups as "Diploid" provides an important context for interpreting the CNV heatmap. The presence of focal CNVs within these "Diploid" groups suggests that ploidy inference at a genome-wide level might not capture all biologically significant copy number changes. This highlights the importance of analyzing both gross aneuploidy and subtle, focal CNVs. The inclusion of "unassigned" cells means their CNV profile should be considered, as it might shed light on their true cellular identity and role in the tumor microenvironment.

5. CNV-Based UMAP Embedding and Cell Annotation Analysis in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a Uniform Manifold Approximation and Projection (UMAP) visualization of single-cell RNA-seq data, specifically embedding cells based on their Copy Number Variation (CNV) estimates (derived from obsm['X_cnv']). This CNV-based embedding allows us to explore the cellular landscape through the lens of genomic alterations, providing insights into cellular identity, ploidy status, and condition-specific patterns. The UMAP plots are colored by various cellular and sample annotations: major cell type, minor cell type, ploidy status, experimental condition (normal/tumor), and individual sample. The goal is to understand how these annotations align with the underlying CNV patterns.

Visual Summary

The UMAP plots, generated using CNV estimates, reveal distinct clustering patterns:

celltype_major & celltype_minor:

ploidy_dec:

condition:

sample:

Biological Interpretation

  1. Identification of Malignant Cells by CNV: The CNV-based UMAP effectively separates cells based on their ploidy status. The distinct cluster of aneuploid cells, predominantly Intestinal Epithelial cells from tumor samples, strongly suggests the successful identification of malignant tumor cells. Aneuploidy, a state of having an abnormal number of chromosomes, is a well-established hallmark of cancer, particularly in solid tumors like those originating from epithelial cells GeneCards: Aneuploidy.
  2. Cell Type Specificity of CNVs: The "Intestinal Epithelial cell" population, identified as the "Tumor origin celltype" in the data context, forms a distinct cluster characterized by aneuploidy and origin from tumor samples. This is consistent with their expected role as the cell type undergoing malignant transformation in colon cancer. Other cell types (immune cells, stromal cells, endothelial cells) primarily exhibit diploid profiles and cluster separately, as expected for non-malignant cells within the tumor microenvironment or normal tissue.
  3. Tumor Microenvironment Composition: The coexistence of diploid cells (immune, stromal, endothelial) from tumor samples within the larger diploid cluster, alongside aneuploid tumor cells, reflects the complex cellular composition of the tumor microenvironment. These diploid cells represent the host response and supporting stroma within the tumor.
  4. Inter-sample Heterogeneity in Tumor CNVs: While all identified tumor cells share the overarching feature of aneuploidy, the sample-specific grouping within the aneuploid cluster hints at diversity in the specific CNV landscapes between individual patient tumors. This genomic heterogeneity can influence tumor behavior, treatment response, and prognosis PubMed Search: Tumor heterogeneity CNV cancer.

Annotation Notes

6. Colon Tissue Minor Cell Type Population Analysis

Report figure

[Analysis Visualization Results]...

Analysis Overview

이 분석은 단일 세포 RNA 시퀀싱 데이터를 사용하여 정상(normal) 및 종양(tumor) 대장 조직 샘플의 마이너 세포 유형 구성을 비교하는 막대 그래프를 제공합니다. 각 막대는 특정 샘플 내의 총 세포 수에 대한 각 세포 유형의 상대적 비율을 나타내어, 샘플 간 및 조건 간의 세포 구성 변화를 시각화합니다.

Visual Summary

주어진 막대 그래프는 정상 및 종양 조건에서 대장 조직의 마이너 세포 유형 구성에 대한 통찰력을 제공합니다.

정상 조직(normal)

종양 조직(tumor)

Biological Interpretation

대장 조직에서 정상과 종양 조건 간의 마이너 세포 유형 구성 변화는 종양 미세 환경(TME)의 재편성을 강력하게 시사합니다.

  1. 상피세포 감소 및 종양 유래 세포의 변화: Intestinal Epithelial cell이 종양 기원 세포 유형으로 명시된 점을 감안할 때, 종양 샘플에서 이 세포 유형의 상대적 감소는 정상 상피 조직이 종양 세포에 의해 대체되거나, 샘플링 과정에서 종양 세포가 비악성 상피세포로 분류되지 않았을 가능성을 나타낼 수 있습니다. 종양 세포는 형태학적 및 유전자 발현 변화를 겪을 수 있어 기존 상피세포 마커 발현이 감소할 수 있습니다.
  2. 섬유아세포(Fibroblast)의 증가: 종양 샘플에서 섬유아세포의 증가 경향은 종양 미세 환경에서 암 관련 섬유아세포(CAFs)의 축적을 나타낼 수 있습니다. CAFs는 세포외 기질(ECM) 리모델링, 면역 억제, 종양 세포 증식 및 전이를 촉진함으로써 종양 진행에 중요한 역할을 합니다 PubMed search: Cancer-Associated Fibroblasts Colon Cancer.
  3. 면역 세포 침윤의 변화:

Clinical or Translational Implications

이러한 세포 유형 구성의 변화는 대장암의 진단, 예후 및 치료에 중요한 임상적 의미를 가집니다.

  1. 생체 지표 발굴: TME 내 특정 세포 유형의 상대적 비율은 잠재적인 예후 또는 예측 생체 지표로 사용될 수 있습니다. 예를 들어, 특정 유형의 면역 세포 침윤 패턴(예: CD8+ T 세포 대 조절 T 세포 비율, B 세포/플라스마 세포 존재 여부)은 환자의 생존율 또는 면역 치료 반응과 연관될 수 있습니다.
  2. 치료 전략 개발:
  1. 환자 층화: 세포 구성의 샘플 간 이질성은 대장암의 다양한 아형(subtype)이 존재하며, 개인 맞춤형 치료 접근법이 필요함을 시사합니다. 각 환자의 TME 프로파일을 특성화하는 것은 최적의 치료법을 선택하는 데 도움이 될 수 있습니다.

이러한 인구 분석은 TME의 기본 구성에 대한 중요한 초기 통찰력을 제공하며, 특정 세포 유형의 기능적 상태 및 상호 작용에 대한 추가 분석(예: DEG, GSEA, CCI)을 통해 보다 심층적인 기계적 이해와 임상적 관련성을 도출할 수 있습니다.

7. T Cell Subset Population Analysis in Colon Normal vs. Tumor Conditions

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a stacked barplot visualizing the relative proportions of T cell subsets, including other innate lymphoid cells (ILCs) and NK cells, within the major "T cell" population across individual samples from normal and tumor colon tissues. The aim is to identify shifts in immune cell composition associated with the disease state.

Visual Summary

The visualization displays the proportional distribution of various lymphoid subsets (T cells, ILCs, NK cells) within each sample, grouped by 'normal' and 'tumor' conditions. Each bar represents a sample, and the colored segments indicate the percentage contribution of each cell type, normalized to 100%.

Tumor Condition Differences:

Biological Interpretation

The observed shifts in lymphoid cell populations provide critical insights into the immune landscape of colon cancer.

Clinical or Translational Implications

The findings have several important clinical and translational implications for colon cancer:

8. Macrophage Subset Population Analysis in Colon Normal vs. Tumor Tissues

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis visualizes the proportional distribution of macrophage subsets (M1, M2A, M2B, M2C, M2D) across individual normal and tumor samples from colon tissue. The single-cell RNA-seq data was analyzed to identify and quantify these macrophage populations, providing insights into potential shifts in the tumor microenvironment (TME).

Visual Summary

The stacked bar plot effectively displays the relative abundance of five distinct macrophage subsets—M1, M2A, M2B, M2C, and M2D—within each analyzed sample. Samples are grouped by condition (normal vs. tumor).

Biological Interpretation

Macrophages are critical immune cells exhibiting significant plasticity, polarizing into various functional states (M1-like and M2-like) that profoundly influence cancer progression and immune responses in the tumor microenvironment.

The co-existence of M1 and various M2 subsets highlights the dynamic and context-dependent nature of macrophage functions within the colon tumor microenvironment. This could imply a scenario where pro-inflammatory M1 responses are present, but their efficacy might be modulated or counteracted by the concurrent presence of immunosuppressive M2 populations.

Clinical or Translational Implications

The observed shifts in macrophage populations have significant implications for understanding colon cancer biology and developing targeted therapies.

---

References:

  1. M1 Macrophages in Cancer:

PubMed search: M1 macrophages anti-tumor immunity cancer

  1. M2 Macrophages in Cancer:

PubMed search: M2 macrophages pro-tumor immunity cancer

  1. M2D Macrophages:

PubMed search: M2D macrophages tumor angiogenesis

  1. Macrophage Polarization as Biomarker:

PubMed search: macrophage M1 M2 ratio cancer prognosis

  1. Targeting Macrophages in Cancer Therapy:

PubMed search: macrophage targeting cancer therapy

9. T Cell Subset Population Shifts in Colon Cancer

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the proportional changes of various T cell subsets within colon tissue when comparing normal conditions to tumor conditions. The aim is to identify specific T cell populations that are significantly altered in the tumor microenvironment, which can provide insights into immune responses and potential immune evasion mechanisms in colon cancer. The results are presented as boxplots, showing the distribution of cell type proportions for each T cell subset across normal and tumor samples, along with statistical significance markers (p-values).

Visual Summary

The boxplots illustrate the relative proportions of T cell subsets (Tfh, Th22, Treg, Th17) in normal versus tumor colon samples.

Notably, Th22, Treg, and Th17 cell populations all exhibit a significant increase in their relative proportions in the tumor microenvironment of the colon.

Biological Interpretation

The observed shifts in T cell subset proportions in colon tumor tissue suggest a significant re-programming of the local immune environment, often indicative of an adaptive immune response tailored by the tumor.

  1. Expansion of Immunosuppressive Treg cells: The most prominent finding is the highly significant increase in Regulatory T cells (Treg cells) within the tumor. Tregs are crucial for maintaining immune tolerance and suppressing effector T cell responses. Their enrichment in the tumor microenvironment (TME) is a well-established mechanism by which tumors evade anti-tumor immunity, often leading to a dampened immune attack against cancer cells. This is a common feature in many cancers, including colorectal cancer. PubMed Search: Treg cells colorectal cancer immune evasion
  2. Increase in Th17 cells: Th17 cells, characterized by their production of IL-17, exhibit a significant increase in the tumor. The role of Th17 cells in cancer is often context-dependent, sometimes promoting anti-tumor immunity but frequently associated with pro-tumorigenic inflammation, angiogenesis, and tumor cell survival, particularly in colorectal cancer. The elevated presence of Th17 cells in the colon TME could contribute to chronic inflammation that supports tumor growth. PubMed Search: Th17 cells colorectal cancer IL-17
  3. Elevation of Th22 cells: The significant increase in Th22 cells in tumor samples is also notable. Th22 cells produce IL-22, which plays a role in tissue repair, inflammation, and host defense. In the context of cancer, IL-22 can promote proliferation, survival, and migration of cancer cells, as well as influence the differentiation of immune cells, potentially contributing to tumor progression in colorectal cancer. PubMed Search: Th22 cells colorectal cancer IL-22
  4. Tfh cells: While Tfh cells show a non-significant trend of decrease, their primary role is in supporting B cell responses within lymphoid follicles. Their presence in the direct tumor infiltrate may be less critical for the immediate anti-tumor response compared to other T cell subsets.

Overall, the data points towards an immune landscape in colon tumors that is significantly skewed towards immunosuppression (high Treg) and pro-tumorigenic inflammation (high Th17 and Th22), collectively hindering effective anti-tumor immunity.

Clinical or Translational Implications

The findings have several potential clinical and translational implications for colon cancer:

10. Differential Macrophage Subset Proportions in Colon Tumor Microenvironment

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the proportional changes of specific macrophage subset populations, namely Mac (M2D), Mac (M2B), and Mac (M2A), between normal colon tissue and colon tumor conditions. Box plots are used to visualize the distribution of celltype proportions, with statistical significance indicated for observed differences. This provides insight into the shifts in the macrophage landscape within the tumor microenvironment.

Visual Summary

The box plots illustrate the celltype proportion for three distinct macrophage subsets when comparing normal and tumor conditions:

Biological Interpretation

Macrophages are highly plastic immune cells that play diverse roles in tissue homeostasis, inflammation, and cancer. The observed shifts in macrophage subset proportions in the colon tumor microenvironment (TME) suggest a reprogramming of these cells, consistent with their known roles in tumor progression:

Collectively, these findings indicate a significant skewing of the macrophage population towards M2-like phenotypes (M2D and M2B) that generally support tumor growth and immune evasion, accompanied by a reduction in macrophages (M2A) typically associated with tissue repair and homeostatic functions. This pattern is a hallmark of many solid tumors, including colorectal cancer.

Clinical or Translational Implications

The observed shifts in macrophage subset proportions hold significant clinical and translational implications for colon cancer:

References

  1. M2 Macrophages and Tumor Progression:

PubMed search: "M2 macrophages tumor progression" OR "TAMs cancer prognosis"

  1. M2B Macrophage Function:

PubMed search: "M2B macrophages cancer" OR "M2B macrophage IL-10"

  1. M2A Macrophage Function:

PubMed search: "M2A macrophages wound healing" OR "M2A macrophage tissue repair"

  1. Macrophage Repolarization in Cancer Therapy:

PubMed search: "macrophage repolarization cancer therapy" OR "TAM targeting immunotherapy"

  1. Macrophage Polarization and Immunotherapy:

PubMed search: "macrophage polarization checkpoint blockade" OR "TAMs immunotherapy resistance"

11. Ploidy Analysis of Tumor-Origin and Unassigned Cells in Normal and Tumor Colon Samples

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the ploidy status (Aneuploid, Diploid, or Unclear) of Intestinal Epithelial cells (the designated tumor-origin cell type) and unassigned cells across various normal and tumor colon samples. The plot visualizes the proportional distribution of these ploidy states for the combined population of these selected cell types within each sample, grouped by condition.

Visual Summary

The bar plot displays the percentage of Aneuploid, Diploid, and Unclear cells within the specified cell populations (Intestinal Epithelial cells and unassigned cells) for each sample, stratified by 'normal' and 'tumor' conditions.

Biological Interpretation

The observed ploidy patterns align well with the expected genetic characteristics of normal and cancerous tissues, especially concerning the designated tumor-origin Intestinal Epithelial cells.

Clinical or Translational Implications

12. Normal Colon Cell-Cell Interaction Patterns Focused on Epithelial and T Cells

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates significant cell-cell interaction (CCI) patterns within the normal colon microenvironment, focusing on Intestinal Epithelial cells (specifically "Diploid Intestinal Epi" as the tumor-origin proxy in normal tissue) and key immune populations (CD4+ and CD8+ T cells). Fibroblasts and Macrophages were also requested but are not prominently displayed in the top 80 interactions for the normal condition plot. The dot plot visualizes the strength (mean expression) and significance (p-value) of ligand-receptor interactions between specified cell type pairs.

Visual Summary

The provided dot plot for the "normal" condition highlights a robust network of interactions primarily among T cells (CD8+, CD4+) and between T cells and Diploid Intestinal Epithelial cells. Homotypic interactions within T cell populations and within Diploid Intestinal Epithelial cells are also observed.

Prominent Interactions across Multiple Cell Pairs:

Key Cell-Cell Interaction Patterns:

Biological Interpretation

The observed CCI patterns in the normal colon tissue provide insights into the maintenance of tissue homeostasis and immune surveillance.

  1. Immune Homeostasis and Surveillance: The extensive homotypic T cell interactions (e.g., CD58-CD2) underscore the importance of direct T-T cell communication for maintaining T cell activation states and coordinating immune responses in the gut. The presence of HLA-E interactions with NKG2A/E on T cells and VSIR-HLA-E/F interactions suggests a crucial role for immune checkpoints in preventing over-activation and maintaining immune tolerance within the intestinal environment, which is constantly exposed to commensal microbiota and food antigens. PubMed search: HLA-E NKG2A immune tolerance gut
  2. Epithelial-Immune Crosstalk for Barrier Function: The reciprocal interactions between Diploid Intestinal Epithelial cells and T cells are vital for the integrity and defense of the intestinal barrier. Epithelial cells can present antigens or express regulatory molecules (e.g., HLA-E, CEACAMs) that modulate local immune responses. This constant communication helps the immune system to distinguish between harmless and harmful stimuli, crucial for gut health. Interactions like CEACAM5-CD8A could be involved in T cell recruitment or activation close to the epithelium. GeneCards: CEACAM5
  3. Widespread Role of Prostaglandin E2 Signaling: The strong and pervasive signal of PGE2 via its receptors (PTGER2/4) across almost all identified cell pairs highlights PGE2 as a key signaling molecule in the normal colon. PGE2 is a lipid mediator with diverse roles, including regulating inflammation, immune cell function (both pro- and anti-inflammatory effects depending on context and receptor expressed), and epithelial cell proliferation/differentiation. In a normal state, this broad signaling likely contributes to balancing immune responses, maintaining epithelial integrity, and facilitating tissue repair. PubMed search: Prostaglandin E2 gut homeostasis
  4. Epithelial Barrier Maintenance: Homotypic interactions among Diploid Intestinal Epithelial cells (e.g., CEACAM5-CEACAM1, DSC2-DSG2, CDH1_integrin_aEb7_complex) are critical for maintaining the tight junctions and cellular adhesion that form the physical barrier of the intestinal lining, preventing uncontrolled translocation of luminal contents.

Clinical or Translational Implications

Understanding the baseline CCI in normal colon tissue is fundamental for discerning pathological changes in disease states such as inflammatory bowel disease (IBD) or colorectal cancer (CRC).

13. Tumor 미세환경 내 Cell-Cell 상호작용 분석: 주요 Ligand-Receptor 쌍 및 생물학적 함의

Report figure

[Analysis Visualization Results]...

Analysis Overview

본 분석은 단일 세포 RNA 시퀀싱 데이터를 기반으로 종양(tumor) 조건에서 세포 간 상호작용(Cell-Cell Interaction, CCI)을 시각화한 결과입니다. plot_cci_dots 툴을 사용하여 CellPhoneDB에서 예측된 리간드-수용체 쌍 상호작용 중 가장 유의미하고 발현량이 높은 상위 80개를 도트 플롯으로 나타냈습니다. 이 플롯은 각 상호작용의 통계적 유의성(-log10(p-value), 점 크기)과 발현량(log2(mean), 점 색상)을 동시에 보여주어 종양 미세환경 내 세포 간 커뮤니케이션 네트워크를 이해하는 데 중요한 통찰력을 제공합니다. 특히, expand_ploidy_from_tumor_origin 파라미터가 적용되어 종양 기원 세포인 장 상피 세포(Intestinal Epithelial cell)가 이배체(Diploid) 여부에 따라 구분되어 분석에 포함되었습니다.

Visual Summary

제공된 도트 플롯은 종양 조건에서 다양한 세포 유형(T CD8+, T CD4+, Plasma cell, B cell, Diploid Intestinal Epi) 간의 리간드-수용체 상호작용을 나타냅니다.

유의미하고 발현량이 높은 상호작용

Biological Interpretation

관찰된 세포-세포 상호작용은 대장암 종양 미세환경(TME)의 복잡한 면역 조절 및 세포 생물학적 과정을 반영합니다.

면역 회피 및 억제 메커니즘

세포 접착 및 이동

케모카인 신호 전달

Clinical or Translational Implications

이러한 세포-세포 상호작용 분석 결과는 대장암의 진단, 예후 예측 및 새로운 치료 전략 개발에 중요한 단서를 제공할 수 있습니다.

14. Cell-Cell Interaction Analysis of Immune Checkpoint and Cell Cycle Related Genes in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates cell-cell interactions (CCI) using CellPhoneDB for a focused set of immune checkpoint and cell cycle-related genes within normal and tumor colon tissues. The goal is to identify significant ligand-receptor interactions involving these specific pathways between different cell types present in the colon microenvironment and observe how these interactions differ between healthy and diseased states. The plot_cci_dots tool was used to visualize the most significant interactions based on p-value and mean expression, aggregating results by 'condition'.

Visual Summary

The dot plots display significant cell-cell interactions for the specified immune checkpoint and cell cycle-related genes. The size of the dot represents the negative log10 of the p-value (-log10(p)), indicating statistical significance (larger dots mean smaller p-values), while the color intensity represents the log2 of the mean expression (log2(m)) of the interacting ligand-receptor pair.

CCI for Normal Condition:

CCI for Tumor Condition:

Comparison:

A key difference is the absence of IFNG_Type_II_IFNR interactions in the tumor condition, which were present in normal tissue. For LCK_CD8_receptor interactions, the mean expression appears higher in the tumor (uniformly 1.0) compared to normal (0.9-1.0), and the T CD8+ | B cell interaction is lost in the tumor microenvironment.

Biological Interpretation

The analysis, focused on immune checkpoint and cell cycle-related genes, reveals specific interactions that are active in normal colon tissue and undergo significant changes in the tumor microenvironment. Notably, despite a broad list of target genes, only a select few interactions met the display criteria, suggesting that many canonical immune checkpoint or cell cycle interactions might not be the most prominent ligand-receptor events in this specific dataset or context.

  1. IFN-γ Signaling (IFNG_Type_II_IFNR):
  1. LCK and CD8-mediated Receptor Signaling (LCK_CD8_receptor):
  1. Overall Context of Target Genes:

Clinical or Translational Implications

  1. Impaired IFN-γ Signaling in Tumor: The striking absence of IFNG_Type_II_IFNR interactions in tumor tissue highlights a potential mechanism of immune evasion. Tumors often develop strategies to suppress IFN-γ production or signaling, leading to a "cold" tumor microenvironment less susceptible to immune attack.
  1. Altered T Cell Communication in Tumor: The sustained but reconfigured LCK_CD8_receptor interactions, with increased mean expression and loss of B cell partnership in the tumor, indicate ongoing T cell activity but also suggest a dysfunctional or rewired immune context. The CD8+ T cells are crucial for directly killing tumor cells.
  1. Prioritization of Targets: The specific appearance of IFNG and LCK-related interactions, while canonical immune checkpoint molecules like PD-1/PD-L1 and CTLA-4 from the input list are not shown, suggests that in this particular colon cancer dataset, these upstream or core T cell activation pathways might be more dysregulated at the ligand-receptor level than the canonical checkpoints, or simply more statistically robust in this analysis setting. This re-prioritization could guide further investigation into IFNG biology or specific LCK-dependent pathways for therapeutic intervention in colon cancer.

15. Condition-Specific Cell-Cell Interaction Patterns in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates statistically significant differences in cell-cell interactions (CCI) between normal and tumor conditions within colon tissue, focusing on major immune and stromal cell types. The dot plot visualizes the top 25 most significantly different CCI pairs for each condition, selected based on their minimum p-value. The size of each dot represents the statistical significance (negative log10 p-value), and the color intensity indicates the standardized mean interaction strength across samples. The interacting cell types include T cells (CD4+, CD8+), B cells, Plasma cells, ILCs, Fibroblasts, Macrophages, Endothelial cells, Mast cells, Smooth muscle cells, NK cells, Dendritic cells, and Intestinal Epithelial cells (specifically, diploid epithelial cells, as denoted by Ent.Epi (Dip)). The AnnData context indicates that Intestinal Epithelial cells are the tumor origin cell type, making their interactions particularly relevant.

Visual Summary

The dot plot displays a distinct pattern of cell-cell interactions, clearly separating interactions characteristic of the "normal" condition from those characteristic of the "tumor" condition.

  1. Distinct Condition-Specific Clusters: Two large blue boxes highlight the primary observation:
  1. Interaction Strength and Significance:
  1. Key Interacting Cell Types: The x-axis labels reveal interactions primarily between various immune cells (T cells, B cells, Plasma cells) and stromal cells, as well as with Intestinal Epithelial cells (Diploid, Ent.Epi (Dip)). This underscores the complex interplay within the tissue microenvironment.

Biological Interpretation

Normal-Associated Cell-Cell Interactions

Interactions prominent in normal colon tissue largely involve immune surveillance, cell adhesion, and homeostatic regulation. These often reflect a healthy, organized immune microenvironment.

Immune Surveillance & Adhesion:

B Cell Activation & Regulation:

T Cell Modulation:

Tumor-Associated Cell-Cell Interactions

The tumor microenvironment (TME) is characterized by distinct interaction patterns that often contribute to immune evasion, tumor progression, and T cell dysfunction.

Immune Checkpoint & T Cell Exhaustion Pathways:

Tumor-Associated Adhesion & Immune Evasion:

Altered T Cell & Plasma Cell Communication:

Role of Diploid Intestinal Epithelial Cells

The prevalence of interactions involving Intestinal Epithelial cell (Dip) is noteworthy. As Intestinal Epithelial cells are identified as the tumor origin cell type, these diploid epithelial cells could represent:

  1. Normal epithelial cells within the tumor microenvironment.
  2. Diploid tumor cell populations or pre-malignant cells, which may interact differently from aneuploid tumor cells (though interactions with aneuploid cells are not explicitly shown here).

The specific engagement of these diploid epithelial cells in immune checkpoint pathways like NECTIN2-TIGIT and tumor-associated signaling like CEACAM5-CD8A suggests their critical role in shaping the local immune response in the context of malignancy.

Clinical or Translational Implications

The differential CCI patterns between normal and tumor conditions offer crucial insights for therapeutic development, particularly in colorectal cancer.

16. Intestinal Epithelial Cell Condition-Specific Surfaceome Markers

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies condition-specific surfaceome markers for Intestinal Epithelial cells. The provided dot plot visualizes the expression of up to 50 surface markers across various individual samples, categorized by their inferred ploidy status and origin (tumor vs. normal-like). The goal is to highlight surface proteins that are differentially expressed, particularly in tumor-origin Intestinal Epithelial cells, compared to normal or diploid counterparts.

Visual Summary

The dot plot effectively displays the mean expression (color intensity) and the fraction of cells expressing a gene (dot size) for each marker across different samples.

Biological Interpretation

This analysis successfully identifies a set of highly specific surfaceome markers that differentiate tumor-origin Intestinal Epithelial cells from their normal or diploid counterparts. The observed differential expression reflects profound molecular changes occurring at the cell surface during colorectal tumorigenesis.

Clinical or Translational Implications

The identification of these surfaceome markers for Intestinal Epithelial cells in the context of tumor vs. normal conditions has significant clinical and translational potential.

Diagnostic and Prognostic Biomarkers:

Therapeutic Targets:

Experimental Validation:

---

References:

  1. MUC4 in cancer: PubMed search for "MUC4 colorectal cancer" https://pubmed.ncbi.nlm.nih.gov/?term=MUC4+colorectal+cancer
  2. CEACAM5 (CEA): GeneCards entry for CEACAM5 https://www.genecards.org/cgi-bin/carddisp.pl?gene=CEACAM5
  3. CEACAM6: GeneCards entry for CEACAM6 https://www.genecards.org/cgi-bin/carddisp.pl?gene=CEACAM6
  4. BSG (CD147): GeneCards entry for BSG https://www.genecards.org/cgi-bin/carddisp.pl?gene=BSG
  5. AREG (Amphiregulin): GeneCards entry for AREG https://www.genecards.org/cgi-bin/carddisp.pl?gene=AREG
  6. CD44: GeneCards entry for CD44 https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD44
  7. CDH1 (E-cadherin) in cancer: PubMed search for "E-cadherin colorectal cancer" https://pubmed.ncbi.nlm.nih.gov/?term=E-cadherin+colorectal+cancer
  8. DPEP1 in cancer: PubMed search for "DPEP1 cancer" https://pubmed.ncbi.nlm.nih.gov/?term=DPEP1+cancer
  9. CD63 in cancer: PubMed search for "CD63 cancer" https://pubmed.ncbi.nlm.nih.gov/?term=CD63+cancer
  10. CEACAM5-targeting therapies: PubMed search for "CEACAM5 antibody drug conjugate" https://pubmed.ncbi.nlm.nih.gov/?term=CEACAM5+antibody+drug+conjugate
  11. BSG/CD147 targeting: PubMed search for "CD147 targeting cancer" https://pubmed.ncbi.nlm.nih.gov/?term=CD147+targeting+cancer
  12. CD44 targeting: PubMed search for "CD44 targeting cancer" https://pubmed.ncbi.nlm.nih.gov/?term=CD44+targeting+cancer

17. Cell-Type Specific Surfaceome Markers for Macrophage Subtypes in Human Colon

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis aimed to identify condition-specific surfaceome markers for macrophages. The provided visualization is a dot plot displaying cell-type specific surfaceome markers across various cell subsets found in human colon tissue, including Macrophage (M1) and Macrophage (M2B) subtypes. While the initial query focused on "condition-specific markers," the output visualizes markers that are highly specific to individual cell types (or subtypes) within the dataset, allowing for differentiation between these populations. The selection was restricted to surfaceome markers, which are particularly valuable for cell sorting, imaging, and therapeutic targeting.

Visual Summary

The dot plot effectively illustrates the expression patterns of selected surfaceome genes across different cell types and subsets, as identified by celltype_subset.

Key observations for Macrophages:

Biological Interpretation

The identified surfaceome markers provide significant biological insights into the distinct characteristics and potential functions of macrophage subtypes in the human colon, which can be critical in both normal physiology and disease states like colon cancer (given the conditions: normal, tumor in the data context).

  1. Macrophage (M1) Polarization Markers:
  1. Macrophage (M2B) Polarization Markers:

Clinical or Translational Implications

The identification of specific surfaceome markers for macrophage subtypes holds significant clinical and translational value, particularly in the context of colon diseases such as inflammatory bowel disease or colorectal cancer (given tissue: Colon and conditions: normal, tumor).

18. Fibroblast Condition-Specific Surfaceome Markers in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies and visualizes condition-specific surfaceome markers in Fibroblasts, comparing 'normal' and 'tumor' conditions within the colon tissue. The dot plot displays the mean expression level (color intensity) and the fraction of cells expressing a gene (dot size) for selected surface markers across different fibroblast sub-clusters (B_cac14, T_cac1, T_cac2, T_cac3) in both normal and tumor contexts. The "surfaceome_only" parameter ensures that only cell surface proteins, which are often key players in cell-cell interactions and amenable to therapeutic targeting, are presented.

Visual Summary

The dot plot clearly differentiates two major groups of fibroblast-expressed surface markers: those enriched in the 'normal' condition (left red box) and those enriched in the 'tumor' condition (right red box).

Biological Interpretation

The distinct sets of surfaceome markers identify clear transcriptional shifts in fibroblasts between normal colon tissue and the tumor microenvironment. This highlights the dynamic adaptation and functional specialization of fibroblasts in response to oncogenic stimuli.

Normal Fibroblast Signatures (B_cac14 cluster)

Fibroblasts in normal colon tissue (represented by the B_cac14 cluster) express markers that suggest roles in tissue homeostasis and basic cellular functions:

Tumor-Associated Fibroblast Signatures (T_cac1, T_cac2, T_cac3 clusters)

Fibroblasts in the tumor microenvironment (CAFs) exhibit a dramatic shift in their surfaceome, acquiring markers that promote tumor growth, invasion, and immune evasion:

Clinical or Translational Implications

The identified condition-specific surfaceome markers in fibroblasts offer significant clinical and translational potential, particularly for colon cancer:

19. Condition-Specific Surfaceome Markers in CD4+ T cells

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis aimed to identify surfaceome markers that are differentially expressed between CD4+ T cells derived from normal colon tissue and those from tumor tissue. The plot_markers_and_expression_dot tool was used to visualize the mean expression and fraction of cells expressing these markers across different samples, grouped by condition. The focus on surfaceome markers is particularly relevant for identifying potential therapeutic targets or biomarkers accessible via cell surface.

Visual Summary

The dot plot effectively visualizes the expression patterns of 30 distinct surfaceome markers across various samples of CD4+ T cells, segregated by their origin (normal vs. tumor colon tissue).

Biological Interpretation

The distinct surfaceome profiles of CD4+ T cells in normal versus tumor colon tissue provide significant biological insights into their functional states and roles within their respective microenvironments.

Normal Colon CD4+ T cells

Immune Checkpoints/Co-regulatory Molecules

Adhesion/Migration/Metabolic Markers

Clinical or Translational Implications

The identification of condition-specific surfaceome markers in CD4+ T cells has several important clinical and translational implications for colon cancer.

20. Intestinal Epithelial Cell Cycle Deregulation in Colon Tumorigenesis

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigated the expression levels of 24 selected cell cycle pathway-related genes in Intestinal Epithelial cells, comparing normal colon tissue to tumor tissue. The goal was to identify statistically significant differences in gene expression that might contribute to the disease state. The plot_box_for_gene_expression_with_signif_difference tool was used, displaying the distribution of gene expression per sample as box plots with individual data points (stripplot) and highlighting significant differences with p-values.

Visual Summary

The box plots reveal a consistent pattern of upregulation for the majority of the analyzed cell cycle-related genes in Intestinal Epithelial cells from tumor samples compared to normal samples. Key observations include:

Significant Upregulation in Tumor Cells (p ≤ 0.05 or p ≤ 0.01):

Tendency Towards Upregulation in Tumor Cells (p < 0.1):

Tendency Towards Downregulation in Tumor Cells (p < 0.1):

Biological Interpretation

The findings strongly suggest a profound dysregulation of cell cycle control mechanisms in Intestinal Epithelial cells during colon tumorigenesis. The observed gene expression changes are consistent with hallmarks of cancer, particularly sustained proliferative signaling and evasion of growth suppressors.

  1. Accelerated Cell Cycle Progression: The significant upregulation of core cell cycle machinery components like CCND1 (Cyclin D1) and CDK4 drives the G1-S phase transition, promoting cell division. Similarly, the increased expression of ANAPC11 and ANAPC5, components of the APC/C, which controls anaphase and mitotic exit by ubiquitinating cell cycle proteins, suggests an actively cycling and potentially hyper-proliferative state. The upregulation of RAD21, a cohesin subunit, also points to active chromosome segregation during rapid cell division.
  2. Oncogenic Drive: The prominent upregulation of the proto-oncogene MYC is a critical finding. MYC is a master regulator of cell proliferation, growth, and metabolism. Its overexpression is a common event in many cancers, driving uncontrolled cell division and contributing to malignant transformation.
  3. Epigenetic Reprogramming: The increased expression of HDAC1 and HDAC2 indicates altered epigenetic regulation in tumor cells. Histone deacetylases modify chromatin structure, typically leading to transcriptional repression. Their upregulation can contribute to silencing tumor suppressor genes or promoting oncogenic pathways, thereby supporting unchecked proliferation [UniProt: P23770 (HDAC1), P84122 (HDAC2)].
  4. DNA Repair and Genomic Instability: Upregulation of PRKDC (DNA-PKcs), a key enzyme in non-homologous end joining (NHEJ) DNA repair, could indicate an increased need for DNA damage repair in rapidly dividing tumor cells. While DNA repair is crucial, an enhanced, potentially error-prone, repair capacity can allow damaged cells to survive and accumulate further mutations, contributing to genomic instability characteristic of cancer.
  5. Dysregulated Protein Degradation: Upregulation of RBX1 and SKP1, components of the SCF E3 ubiquitin ligase complexes, suggests altered proteasomal degradation of cell cycle regulators. SCF complexes target proteins for degradation, promoting cell cycle progression. Their overexpression can lead to the inappropriate degradation of cell cycle inhibitors, further driving proliferation.
  6. Altered Signal Transduction (14-3-3 Proteins): The consistent upregulation of multiple 14-3-3 family proteins (YWHAB, YWHAE, YWHAH, YWHAQ, YWHAZ) is notable. These proteins act as crucial signaling adaptors, modulating the activity of a wide array of proteins involved in cell cycle control, apoptosis, signal transduction, and cell survival. Their increased expression can collectively contribute to an environment favoring cell growth, survival, and evasion of apoptotic signals in cancer cells [PubMed Search: 14-3-3 proteins cancer role].
  7. Loss of Growth Arrest Signals: The trend of GADD45B downregulation in tumor cells is significant. GADD45 proteins are typically induced by stress and play roles in cell cycle arrest, DNA repair, and apoptosis. Reduced GADD45B expression could impair crucial cell cycle checkpoints, allowing damaged or abnormal cells to proliferate without proper control [GeneCards: GADD45B].

Clinical or Translational Implications

The pervasive upregulation of cell cycle-promoting genes and downregulation of growth arrest genes in Intestinal Epithelial cells of colon tumors highlights critical pathways that can be exploited for therapeutic intervention.

21. Intestinal Epithelial Cell Gene Ontology (GSA) Analysis: Ploidy and Tumor-Associated Pathway Shifts

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the biological pathways enriched in Intestinal Epithelial cells under two different comparison contexts using Gene Set Analysis (GSA), specifically Gene Ontology (GO) enrichment. The results are presented as bar plots, showing the -log(p-val) and -log(q-val) for significantly upregulated pathways.

Two comparisons were performed:

  1. Diploid_vs_others: Identifies pathways upregulated in Intestinal Epithelial cells classified as Diploid compared to those with other ploidy states (likely Aneuploid cells, based on obs['ploidy_dec']).
  2. Tumor_vs_others: Identifies pathways upregulated in Intestinal Epithelial cells from 'tumor' conditions compared to those from 'normal' conditions.

The goal is to understand the functional characteristics and potential mechanisms distinguishing these cellular states within the colon epithelium.

Visual Summary

  1. GSA_up for Intestinal Epithelial cell: Diploid_vs_others

The bar plot for Diploid vs. others shows a range of significantly upregulated pathways in diploid Intestinal Epithelial cells. The top enriched terms include:

  1. GSA_up for Intestinal Epithelial cell: tumor_vs_others

This plot displays pathways significantly upregulated in Intestinal Epithelial cells from tumor samples compared to normal samples. The enrichment signals are generally much stronger (higher -log(p-val) and -log(q-val)) than in the Diploid_vs_others comparison, indicating more pronounced functional shifts. Key enriched categories include:

Biological Interpretation

Insights from Diploid Intestinal Epithelial Cells:

The upregulation of pathways like FoxO signaling, ErbB signaling, and Apoptosis in diploid epithelial cells (relative to aneuploid cells) may represent mechanisms crucial for maintaining cellular homeostasis, regulating proliferation, and preventing uncontrolled growth. FoxO signaling, for instance, is known to induce cell cycle arrest and apoptosis, acting as a tumor suppressor [1]. The presence of various cancer-related pathways could imply that even diploid cells within the colon (potentially pre-cancerous or in a non-aggressive tumor context) are already undergoing molecular changes, or that these pathways represent general cellular processes that are often co-opted or dysregulated in different cancers. The enrichment of "Tight junction" pathways underscores the role of diploid cells in maintaining epithelial barrier function, which is often compromised in advanced cancers.

Insights from Tumor Intestinal Epithelial Cells:

The pronounced enrichment of pathways related to protein synthesis, processing, and metabolism in tumor epithelial cells is highly consistent with the 'Warburg effect' and the increased biosynthetic demands of rapidly proliferating cancer cells [2]. Upregulation of the Ribosome, Proteasome, and processes in the ER (protein processing) indicates a high rate of protein turnover and biogenesis necessary for rapid growth. Similarly, altered oxidative phosphorylation and TCA cycle activity highlight metabolic reprogramming that supports tumor survival and proliferation.

The strong signal for infection-related pathways is a critical finding for colorectal cancer (CRC). Chronic inflammation, often triggered by bacterial or viral infections, is a known risk factor for CRC [3, 4]. The presence of pathways related to diverse pathogens within tumor epithelial cells themselves suggests that these cells may be directly responding to microbial stimuli or harboring persistent infections that contribute to tumorigenesis, inflammation, or immune evasion. This warrants further investigation into the specific roles of the microbiome and viral agents in colon cancer progression.

The appearance of neurodegenerative disease pathways should be interpreted cautiously. These pathways often involve mechanisms such as protein misfolding, aggregation, mitochondrial dysfunction, and oxidative stress, which are general cellular stressors and hallmarks of many diseases, including cancer, not just neurological ones [5]. Thus, their enrichment in tumor cells likely reflects heightened cellular stress and dysfunctional protein handling rather than a direct neurological link to colon cancer.

The combined dysregulation of Tight junction and Adherens junction pathways in tumor cells is a key indicator of altered cell-cell adhesion, which is fundamental to epithelial-mesenchymal transition (EMT), invasion, and metastasis in cancer [6].

Clinical or Translational Implications

The GSA results provide valuable insights into the biological underpinnings of colon cancer progression, offering potential avenues for therapeutic intervention and biomarker discovery:

References:

[1] GeneCards: FOxO Signaling Pathway. https://www.genecards.org/Pathway/FOXO

[2] PubMed Search: Warburg effect cancer metabolism. https://pubmed.ncbi.nlm.nih.gov/?term=Warburg+effect+cancer+metabolism

[3] PubMed Search: microbiome colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/?term=microbiome+colorectal+cancer

[4] PubMed Search: viral infection colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/?term=viral+infection+colorectal+cancer

[5] PubMed Search: protein misfolding cancer neurodegeneration. https://pubmed.ncbi.nlm.nih.gov/?term=protein+misfolding+cancer+neurodegeneration

[6] PubMed Search: tight junction adherens junction EMT cancer. https://pubmed.ncbi.nlm.nih.gov/?term=tight+junction+adherens+junction+EMT+cancer

22. Major Cell Type GSEA for Colon Tissue: Insights into Tumor Microenvironment Pathways

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents Gene Set Enrichment Analysis (GSEA) results visualized as a dot plot, focusing on key signaling pathways and disease mechanisms across major cell types in human colon tissue under normal and tumor conditions. The analysis compares gene expression profiles to identify pathways that are significantly enriched or depleted in specific cell populations and conditions. The investigated cell types include Intestinal Epithelial cells, T cell CD4+, T cell CD8+, Fibroblast, and B cell. Notably, while Macrophage was requested, it is not displayed in the provided plot. For Intestinal Epithelial cells, comparisons also include ploidy status (Diploid vs. Aneuploid), which is a crucial aspect in cancer biology.

Visual Summary

The dot plot effectively summarizes GSEA results, with each dot representing a specific gene set (pathway) enrichment for a given cell type and comparison.

Key Visual Observations:

  1. Intestinal Epithelial Cells (IECs):
  1. Immune Cells (T cell CD4+, T cell CD8+, B cell):
  1. Fibroblasts:

Biological Interpretation

The GSEA results provide a comprehensive view of pathway activity shifts in different cell types within the colon tumor microenvironment.

Clinical or Translational Implications

  1. Targeting Core Pathways: The consistent enrichment of MAPK, Ras, FoxO, TGF-beta, and TNF signaling pathways across multiple tumor-associated cell types (IECs, T cells, B cells, Fibroblasts) suggests these pathways are central to colon cancer progression. Targeting these pathways could offer broad therapeutic benefits, potentially by inhibiting tumor growth directly (in IECs) and by modulating the pro-tumorigenic functions of stromal and immune cells in the TME.
  2. Cell-Type-Specific Interventions: Understanding which cell types activate specific pathways can guide the development of more precise, cell-type-specific therapies. For example, simultaneously targeting Ras/MAPK in tumor cells and CAFs could be more effective than targeting only one cell type.
  3. Prognostic and Predictive Biomarkers: The distinct pathway signatures, particularly the enrichment of cancer pathways in aneuploid IECs, could serve as prognostic indicators for disease aggressiveness or as predictive biomarkers for response to specific therapies.
  4. Immunotherapy Strategies: The altered signaling in tumor-infiltrating T and B cells, particularly involving TGF-beta and TNF, highlights potential avenues for improving immunotherapy efficacy by counteracting immunosuppressive mechanisms or enhancing anti-tumor immune responses within the TME.
  5. Macrophage Data Gap: The absence of Macrophage data, despite its request, is a limitation. Given Macrophages (especially M2-like) are significant contributors to the TME in colon cancer, their pathway enrichment analysis would provide further crucial insights into the immune landscape and potential therapeutic targets.

23. Discussion

The comprehensive single-cell analysis of human colon tissue provides a granular understanding of the cellular and molecular adaptations within the tumor microenvironment (TME). The identification of Intestinal Epithelial cells as the tumor origin is strongly supported by their aneuploid status, recurrent genomic amplifications (notably affecting MYC on chromosome 8 and genes on 19q), and widespread activation of cell cycle and oncogenic pathways (MAPK, Ras, FoxO, Pyrimidine metabolism). This malignant transformation is accompanied by a profound remodeling of the surrounding stromal and immune compartments.

A striking observation is the significant increase in cancer-associated fibroblasts (CAFs) in tumor samples, which exhibit a highly activated, pro-tumorigenic surfaceome profile (e.g., MMP14, ANTXR1, ITGAV) and extensive enrichment of cancer-related signaling pathways (MAPK, Ras, TGF-beta, TNF). CAFs emerge as central orchestrators of tumor progression, actively engaging in ECM remodeling and creating a supportive niche for tumor cells.

The immune landscape within the TME is characterized by a notable shift towards immunosuppression and chronic inflammation. Specifically, there is a highly significant expansion of regulatory T cells (Tregs), Th17, and Th22 populations. Tregs actively suppress anti-tumor immunity, while Th17 and Th22 cells often contribute to pro-tumorigenic inflammation and tissue repair in the context of cancer. This indicates a TME that actively dampens effective anti-tumor immune responses. Macrophage populations also undergo re-polarization, with an increase in pro-tumorigenic M2D and M2B subsets, despite a sustained M1-like presence. This complex macrophage phenotype suggests a dual role of immune activation and suppression, where M1 may attempt to combat the tumor but is likely counteracted by M2-mediated immunosuppression.

Cell-cell interaction analysis reveals a profound rewiring of intercellular communication in the tumor. The absence of beneficial IFN-γ signaling and the emergence of critical immune checkpoints such as NECTIN2-TIGIT, BTLA-TNFRSF14, and SIRPG-CD47 in the tumor context underscore active immune evasion strategies employed by tumor cells and their associated stromal/immune components. Furthermore, epithelial-immune interactions involving CEACAM5 and CD8A suggest direct impact on T cell function.

Perhaps one of the more unexpected and notable findings is the significant enrichment of numerous infection-related pathways (e.g., Salmonella, pathogenic E. coli, Epstein-Barr virus, HIV) in tumor Intestinal Epithelial cells identified through Gene Ontology analysis. While chronic inflammation is a known risk factor for colorectal cancer, the direct implication of diverse pathogen-related pathways within the tumor epithelial cells themselves suggests a deeper, potentially causative or exacerbating role of microbial stimuli in driving or maintaining the malignant phenotype. This finding warrants further investigation into the direct interaction between pathogens, host immune responses, and epithelial cell transformation in colon cancer. The co-enrichment of neurodegenerative disease pathways in tumor cells, though seemingly unrelated, likely reflects general cellular stressors such as protein misfolding and mitochondrial dysfunction prevalent in aggressive cancers. Overall, these analyses provide a high-resolution map of colon cancer, highlighting genomic instability, metabolic reprogramming, and a highly sophisticated immune evasion landscape.

Hypotheses:

  1. The recurrent amplifications, particularly involving the MYC oncogene on chromosome 8 and regions on 19q, drive the initial malignant transformation or enhance the aggressive phenotype of colon cancer epithelial cells, even in the context of overall diploidy.
  2. The dominant M1 macrophage population in colon tumors, despite the presence of pro-tumorigenic M2 subsets, represents a sustained host anti-tumor immune response that is ultimately overcome or modulated by other immunosuppressive mechanisms, such as increased Tregs and immune checkpoint activation.
  3. The observed enrichment of infection-related pathways within tumor Intestinal Epithelial cells suggests that specific microbial interactions or chronic infections contribute directly to colon cancer progression, potentially by promoting inflammation, genomic instability, or epithelial-mesenchymal transition.
  4. Cancer-associated fibroblasts (CAFs) actively reprogram the tumor microenvironment through diverse surface interactions and cytokine production (e.g., via TGF-beta and TNF signaling), fostering immune evasion and tumor metastasis, with specific CAF subtypes exhibiting distinct pro-tumorigenic functions.
  5. The loss of IFN-γ signaling and upregulation of inhibitory immune checkpoints (e.g., TIGIT, BTLA, CD47) in the tumor microenvironment are central mechanisms through which colon cancer cells and associated immune cells suppress effective anti-tumor immunity.

Potential therapeutic targets:

  1. MYC oncogene: MYC is a potent proto-oncogene frequently amplified and overexpressed in colorectal cancer, driving cell proliferation, growth, and survival. Its amplification was recurrently observed in tumor-origin Intestinal Epithelial cells. Evidence: Recurrent amplifications on chromosome 8q21.3:8q24.21, encompassing the MYC locus, were observed in tumor samples (Section 4). MYC upregulation was also seen in cell cycle analysis (Section 20) and enriched pathways (Section 22). Validation: Investigate the efficacy of MYC inhibitors or strategies to destabilize MYC protein in colon cancer cell lines and organoids with MYC amplification, followed by in vivo efficacy studies.
  2. CEACAM5: CEACAM5 is a known tumor marker frequently overexpressed in colorectal cancer, implicated in cell adhesion, proliferation, and immune evasion, making it an ideal surface-accessible target. Evidence: Highly and specifically upregulated on tumor-origin Intestinal Epithelial cells (Section 16). Involved in tumor-associated cell-cell interactions (CEACAM5-CD8A, Section 13, 15). Validation: Evaluate the anti-tumor efficacy of CEACAM5-targeting antibody-drug conjugates (ADCs) or CAR T-cells in colon cancer models that express high levels of CEACAM5.
  3. TIGIT: TIGIT is an immune checkpoint receptor that suppresses anti-tumor immunity when engaged by its ligands (e.g., NECTIN2) on tumor cells or other TME components. Blocking TIGIT can reactivate exhausted T cells. Evidence: NECTIN2-TIGIT interaction was highly prominent and significantly enriched in tumor samples, particularly between diploid Intestinal Epithelial cells and CD4+ T cells (Section 15). Validation: Test the therapeutic potential of anti-TIGIT antibodies, alone or in combination with other immune checkpoint inhibitors (e.g., anti-PD-1), in colon cancer patient-derived xenograft (PDX) models or syngeneic models.
  4. CTLA4: CTLA4 is a critical inhibitory receptor on T cells, dampening T cell responses and promoting immune evasion. Its upregulation in tumor-infiltrating CD4+ T cells suggests a mechanism of immune suppression. Evidence: Significantly upregulated as a tumor-specific surface marker in CD4+ T cells in tumor conditions (Section 19). Validation: Assess the impact of CTLA4 blockade (e.g., with ipilimumab or novel antibodies) on CD4+ T cell activation, proliferation, and anti-tumor efficacy in colon cancer models.
  5. MMP14 / ANTXR1: MMP14 is a key enzyme for extracellular matrix degradation and tumor invasion. ANTXR1 is linked to angiogenesis and tumor growth. Both are highly expressed by cancer-associated fibroblasts (CAFs), which are crucial for tumor progression. Evidence: MMP14 and ANTXR1 are significantly upregulated as tumor-specific surface markers in fibroblasts from tumor samples (Section 18). Validation: Develop and test inhibitors or antibodies targeting MMP14 or ANTXR1 to modulate CAF function, reduce ECM remodeling, and inhibit tumor invasion/angiogenesis in colon cancer models.
  6. ENTPD1 (CD39): CD39 is an ectonucleotidase involved in adenosine production, a potent immunosuppressive molecule in the tumor microenvironment, and is expressed on immunosuppressive T cells. Evidence: Upregulated as a tumor-specific surface marker in CD4+ T cells in tumor conditions (Section 19). Validation: Evaluate CD39 inhibitors to counteract adenosine-mediated immunosuppression and enhance anti-tumor immunity in colon cancer models.

Follow-up validation ideas:

  1. Confirm MYC amplification and 19q gains in tumor epithelial cells using targeted qPCR or fluorescence in situ hybridization (FISH) on a larger cohort of colorectal cancer samples, correlating findings with clinical outcomes.
  2. Validate the increased proportions of Tregs (FOXP3, CTLA4), Th17 (RORC, IL-17), Th22 (IL-22), M2D/M2B macrophages (CD163, CD206, CD39), and M1 macrophages (CD80, CD86, IFNGR1) in tumor tissue via multiplex immunohistochemistry or flow cytometry on fresh tumor biopsies.
  3. Functionally validate critical immune checkpoint interactions (e.g., NECTIN2-TIGIT, SIRPG-CD47) and tumor-promoting adhesion molecules (e.g., CEACAM5-CD8A) using CRISPR-mediated gene editing in colon cancer cell lines and co-culture systems with immune cells, followed by in vivo tumor growth and immune infiltration studies.
  4. Investigate the specific microbial species associated with colon tumors showing high enrichment of infection-related pathways. Perform in vitro co-culture experiments with candidate pathogens and normal/transformed colon epithelial cells to assess impacts on proliferation, inflammation, and immune evasion.
  5. Use spatial transcriptomics or proteomics to map the distribution and functional states of distinct CAF subsets (identified by markers like MMP14, ANTXR1, CDH11) within the colon tumor microenvironment and correlate their proximity to immune cells and tumor cells with tumor progression markers.
  6. Validate key differentially expressed surface markers (e.g., MUC4, CEACAM5, CD44 on tumor epithelial cells; CTLA4, CD39 on CD4+ T cells; MMP14, ANTXR1 on fibroblasts) using larger, independent cohorts of colon cancer patients via bulk RNA-seq, proteomics, or advanced multiplex imaging to assess prognostic or predictive value.
  7. Employ specific inhibitors for highly enriched oncogenic pathways (e.g., MAPK, Ras, TGF-beta) and cell cycle regulators (e.g., CDK4/6, HDACs) in patient-derived organoids or xenograft models to assess their impact on tumor growth and TME composition.

Limitations:

The interpretations presented herein are derived from a single-cell RNA-sequencing dataset and computational analyses. While robust, these findings are correlative and require further experimental validation to establish causality. The inferred CNVs and ploidy status are computational estimates and may not capture all genomic alterations. The functional states of immune cells are inferred from marker expression and pathway enrichment and would benefit from direct functional assays. The observed inter-sample heterogeneity underscores the complexity of colon cancer and suggests that findings from this cohort may not be universally applicable to all colorectal cancer subtypes or stages. The absence of certain cell types (e.g., Macrophages in GSEA) or specific ligand-receptor interactions from visualization does not necessarily imply their biological irrelevance, but rather reflects the applied filtering thresholds and the scope of the presented analyses.

24. Query List

  1. Show UMAPs for condition, sample, major cell type, minor cell type, ploidy_dec, and celltype_subset in 2 columns and save them.
  2. Show expression of CD3D CD4 CD8A CD79A MS4A1 MZB1 CD14 LYZ FBLN1 NOTCH3 EPCAM MUC1 CD34 genes on UMAP along with minor cell type annotation. Set ncols=4 and save.
  3. Show the overall Celltype_subset marker expression dot plot and save it. Keep target_cell as None and keep the other arguments at their default values.
  4. Select tumor-origin cells (Intestinal Epithelial cell) and unassigned cells, group by sample, show a CNV heatmap, and include a summary of significantly amplified regions. Save the results.
  5. Show CNV patterns as a UMAP. Include major cell type, minor cell type, ploidy results, condition, and sample in 2 columns, and save it.
  6. Show a population bar plot of minor cell types and save it.
  7. Show a subset population barplot for T cells and save it.
  8. Show a subset population barplot for macrophages and save it.
  9. For T cell subset populations, show a boxplot for statistically significant differences between conditions and save it. Determine ncols appropriately based on the total number of panels.
  10. For macrophage subset populations, show a boxplot for statistically significant differences between conditions and save it. Determine ncols appropriately based on the total number of panels.
  11. Select tumor-origin cells (Intestinal Epithelial cell) and unassigned cells, show a bar plot of their ploidy population, and save it.
  12. Show cell-cell interaction patterns including tumor-origin cells (Intestinal Epithelial cell), fibroblasts, macrophages, and T cells by condition and save them. Select up to 80 cell-cell interactions per condition.
  13. Show cell-cell interactions by condition and save the result. Select at most 80 cell-cell interactions for each condition.
  14. Select only immune checkpoint and cell cycle pathway-related genes, show cell-cell interactions for these genes, and save them.
  15. Find statistically significant differences in cell-cell interactions between conditions for major immune and stromal cells, show them as a dot plot, and save it. Set max_n_items_per_group = 25.
  16. Show the condition-specific markers for tumor-origin cells (Intestinal Epithelial cell) as a dot plot and save the result. Use only surfaceome markers, up to 50 markers per condition.
  17. Extract condition-specific markers for macrophages, show them as a dot plot, and save it. Show only surfaceome markers, up to 50 per condition.
  18. Extract condition-specific markers for fibroblasts, show them as a dot plot, and save it. Show only surfaceome markers, up to 50 per condition.
  19. Extract condition-specific markers for CD4 T cells, show them as a dot plot, and save it. Show only surfaceome markers, up to 50 per condition.
  20. For major disease-related cell types (Intestinal Epithelial cell, Fibroblast, Macrophage, T cell), find statistically significant differences in expression between conditions for cell cycle pathway-related genes, show them as a box plot, and save it. Set max_n_items_to_plot = 24, and set ncols appropriately so that the width-to-height ratio of the overall panel is approximately 2x3.
  21. Show Gene Ontology (GSA) analysis results for epithelial cells as bar plots and save the result.
  22. Show a dot plot of Gene set enrichment analysis (GSEA) results for major cell types (Intestinal Epithelial cell, T cell CD4+, T cell CD8+, Fibroblast, Macrophage, B cell) and save it. Set color map to RdBu_r and n_pws_to_show = 80.
↑ Top